These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 24747429)

  • 1. Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study.
    Nolen BM; Brand RE; Prosser D; Velikokhatnaya L; Allen PJ; Zeh HJ; Grizzle WE; Huang Y; Lomakin A; Lokshin AE
    PLoS One; 2014; 9(4):e94928. PubMed ID: 24747429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
    Moore LE; Pfeiffer RM; Zhang Z; Lu KH; Fung ET; Bast RC
    Cancer; 2012 Jan; 118(1):91-100. PubMed ID: 21717433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection.
    Fahrmann JF; Schmidt CM; Mao X; Irajizad E; Loftus M; Zhang J; Patel N; Vykoukal J; Dennison JB; Long JP; Do KA; Zhang J; Chabot JA; Kluger MD; Kastrinos F; Brais L; Babic A; Jajoo K; Lee LS; Clancy TE; Ng K; Bullock A; Genkinger J; Yip-Schneider MT; Maitra A; Wolpin BM; Hanash S
    Gastroenterology; 2021 Mar; 160(4):1373-1383.e6. PubMed ID: 33333055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Serum Biomarker Panels for the Early Detection of Pancreatic Cancer.
    Song J; Sokoll LJ; Pasay JJ; Rubin AL; Li H; Bach DM; Chan DW; Zhang Z
    Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):174-182. PubMed ID: 30333219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum biomarker panels for the detection of pancreatic cancer.
    Brand RE; Nolen BM; Zeh HJ; Allen PJ; Eloubeidi MA; Goldberg M; Elton E; Arnoletti JP; Christein JD; Vickers SM; Langmead CJ; Landsittel DP; Whitcomb DC; Grizzle WE; Lokshin AE
    Clin Cancer Res; 2011 Feb; 17(4):805-16. PubMed ID: 21325298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma.
    Poruk KE; Firpo MA; Scaife CL; Adler DG; Emerson LL; Boucher KM; Mulvihill SJ
    Pancreas; 2013 Mar; 42(2):193-7. PubMed ID: 23407481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Feasibility of Serum Multiple Tumor Markers Test Between Patients with Primary Pancreatic Cancer and Those with Benign Pancreatic Cystic Disease.
    Lee JH
    Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Performance of a Novel Multiplex Immunoassay in Colorectal Cancer.
    Dressen K; Hermann N; Manekeller S; Walgenbach-Bruenagel G; Schildberg FA; Hettwer K; Uhlig S; Kalff JC; Hartmann G; Holdenrieder S
    Anticancer Res; 2017 May; 37(5):2477-2486. PubMed ID: 28476816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Micro-RNA Alterations Appear Late in Pancreatic Cancer.
    Franklin O; Jonsson P; Billing O; Lundberg E; Öhlund D; Nyström H; Lundin C; Antti H; Sund M
    Ann Surg; 2018 Apr; 267(4):775-781. PubMed ID: 28425921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.
    Zhu CS; Pinsky PF; Cramer DW; Ransohoff DF; Hartge P; Pfeiffer RM; Urban N; Mor G; Bast RC; Moore LE; Lokshin AE; McIntosh MW; Skates SJ; Vitonis A; Zhang Z; Ward DC; Symanowski JT; Lomakin A; Fung ET; Sluss PM; Scholler N; Lu KH; Marrangoni AM; Patriotis C; Srivastava S; Buys SS; Berg CD;
    Cancer Prev Res (Phila); 2011 Mar; 4(3):375-83. PubMed ID: 21372037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of serum parameters panels for the early detection of pancreatic cancer.
    Zhang P; Zou M; Wen X; Gu F; Li J; Liu G; Dong J; Deng X; Gao J; Li X; Jia X; Dong Z; Chen L; Wang Y; Tian Y
    Int J Cancer; 2014 Jun; 134(11):2646-55. PubMed ID: 24615168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of blood biomarker candidates for detection of pancreatic cancer.
    Chen R; Crispin DA; Pan S; Hawley S; McIntosh MW; May D; Anton-Culver H; Ziogas A; Bronner MP; Brentnall TA
    Pancreas; 2010 Oct; 39(7):981-8. PubMed ID: 20467349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth differentiation factor (GDF-15) concentration combined with Ca125 levels in serum is superior to commonly used cancer biomarkers in differentiation of pancreatic mass.
    Hogendorf P; Durczyński A; Skulimowski A; Kumor A; Poznańska G; Strzelczyk J
    Cancer Biomark; 2018 Feb; 21(3):505-511. PubMed ID: 29171983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9.
    Makawita S; Dimitromanolakis A; Soosaipillai A; Soleas I; Chan A; Gallinger S; Haun RS; Blasutig IM; Diamandis EP
    BMC Cancer; 2013 Sep; 13():404. PubMed ID: 24007603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved diagnosis of pancreatic adenocarcinoma using haptoglobin and serum amyloid A in a panel screen.
    Firpo MA; Gay DZ; Granger SR; Scaife CL; DiSario JA; Boucher KM; Mulvihill SJ
    World J Surg; 2009 Apr; 33(4):716-22. PubMed ID: 19082654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview.
    Bünger S; Laubert T; Roblick UJ; Habermann JK
    J Cancer Res Clin Oncol; 2011 Mar; 137(3):375-89. PubMed ID: 21193998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis.
    Staal B; Liu Y; Barnett D; Hsueh P; He Z; Gao C; Partyka K; Hurd MW; Singhi AD; Drake RR; Huang Y; Maitra A; Brand RE; Haab BB
    Clin Cancer Res; 2019 May; 25(9):2745-2754. PubMed ID: 30617132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential biomarkers for early detection of pancreatic ductal adenocarcinoma.
    Kriz D; Ansari D; Andersson R
    Clin Transl Oncol; 2020 Dec; 22(12):2170-2174. PubMed ID: 32447642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel serum tumor marker, RCAS1, in pancreatic diseases.
    Yamaguchi K; Enjoji M; Nakashima M; Nakamuta M; Watanabe T; Tanaka M
    World J Gastroenterol; 2005 Sep; 11(33):5199-202. PubMed ID: 16127752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of Early Check-Up of Carbohydrate Antigen 19-9 Levels for Pancreatic Cancer Screening in Asymptomatic New-Onset Diabetic Patients.
    Choe JW; Kim JS; Kim HJ; Hwang SY; Joo MK; Lee BJ; Kim JH; Yeon JE; Park JJ; Byun KS; Bak YT
    Pancreas; 2016; 45(5):730-4. PubMed ID: 26646277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.